Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification of Sudden Unexpected Death in Infant Based on Biomarkers - Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome

NCT06244433 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT06244433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06244433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification of Sudden Unexpected Death in Infant Based on Biomarkers - Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 27, 2024
Completion date
October 27, 2027
Enrollment
650 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

sudden infant death, sudden unexplained infant death